Ayuba B. Dawurung

ORCID: 0000-0001-9830-3277
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mosquito-borne diseases and control
  • SARS-CoV-2 detection and testing
  • Malaria Research and Control
  • SARS-CoV-2 and COVID-19 Research
  • Child Nutrition and Water Access
  • Diverse Scientific Research Studies
  • Computational Drug Discovery Methods
  • COVID-19 Clinical Research Studies
  • Parasites and Host Interactions
  • Respiratory viral infections research
  • Global Maternal and Child Health

Institute of Human Virology
2021-2024

Serosurveillance can provide estimates of population-level exposure to infectious pathogens and has been used extensively during the COVID-19 pandemic. Simultaneous, serological testing for multiple be done using bead-based immunoassays add value disease-specific serosurveys. We conducted a validation four SARS-CoV-2 antigens-full-length spike protein, two receptor binding domain proteins, nucleocapsid protein-on our existing multiplex bead assay (MBA) enteric diseases, malaria, vaccine...

10.4269/ajtmh.22-0078 article EN cc-by American Journal of Tropical Medicine and Hygiene 2022-06-27

ABSTRACT. The first nationally representative, population-based study of schistosomiasis seroprevalence in Nigeria was conducted using blood samples and risk-factor data collected during the 2018 HIV/AIDS Indicator Impact Survey (NAIIS). Schistosomiasis estimated by analyzing for reactivity to schistosome soluble egg antigen (SEA) a multiplex bead assay; NAIIS survey were assessed identify potential risk factors seropositivity. SEA antibody available 31,459 children aged 0 14 years. Overall...

10.4269/ajtmh.23-0219 article EN cc-by American Journal of Tropical Medicine and Hygiene 2023-11-27

Objective There is a need for reliable serological assays to determine accurate estimates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence. Most single target antigen have shown some limitations in Africa. To assess the performance multi-antigen assay, we evaluated commercially available SARS-CoV-2 Multi-Antigen IgG assay human disease 2019 (COVID-19) Nigeria. Methods Validation xMAP was carried out using well-characterized reverse transcription polymerase chain...

10.1371/journal.pone.0266184 article EN public-domain PLoS ONE 2022-04-01

Multiplex assays for malaria antigen detection can gather data from large sample sets, but considerations the consistency and quality assurance (QA) of mass testing lack evaluation. We present a QA framework study occurring November 2019 to March 2020 involving 504 assay plates detecting four Plasmodium antigens: pan-Plasmodium aldolase lactate dehydrogenase (LDH), histidine-rich protein 2 (HRP2), P. vivax LDH (PvLDH). Controls on each plate included buffer blank, negative blood, 4-point...

10.1038/s41598-021-92723-w article EN cc-by Scientific Reports 2021-06-24

Characterization of serological responses to Plasmodium falciparum (Pf) is interest understand disease burden and transmission dynamics; however, their interpretation challenging. Dried blood spots from 30,815 participants aged 6 months 15 years the 2018 Nigeria HIV/AIDS Indicator Impact Survey were analyzed by multiplex bead-based assay measure immunoglobulin G (IgG) Pf-stage-specific MSP-1, AMA-1, GLURPR0, LSA-1, CSP. These IgG levels principal component analysis (PCA). PC1 PC2 scores...

10.1038/s41598-024-74236-4 article EN cc-by Scientific Reports 2024-12-27
Coming Soon ...